Skip to content
AnalystLens

CELESTICA INC 8-K Report, Regulation FD Disclosure (Oct 30, 2025)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed October 30, 2025
Period End
October 30, 2025
Security
CLS
In the record · 2016–202610-K1210-Q58-K181

CLS filed 12 annual reports (10-K), 5 quarterly reports (10-Q) and 181 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed October 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Celestica Inc. (CLS) has announced its intention to initiate a Normal Course Issuer Bid (NCIB) to repurchase up to approximately 5%a of its outstanding common shares.

This bid, representing about 5,722,527 shares, will commence on November 3, 2025, and run for a period of 12 months, concluding on November 2, 2026. The company has received final acceptance for this program from the Toronto Stock Exchange, indicating a strategic move to return capital to shareholders and potentially enhance shareholder value. This NCIB reflects management's confidence in the company's financial position and its outlook.

Investors should view this as a signal that Celestica believes its shares may be undervalued, or as a method to manage its capital structure effectively. The program's size, set at 5%b of the public float, is within the typical range for such initiatives and suggests a measured approach to share repurchases.

Key Highlights

  1. Celestica Inc. (CLS) has received approval for a Normal Course Issuer Bid (NCIB).
  2. The company plans to repurchase up to 5,722,527 common shares, representing approximately 5% of the outstanding public float.
  3. The NCIB is scheduled to begin on November 3, 2025, and will conclude on November 2, 2026.
  4. This program allows Celestica to return capital to shareholders.
  5. The NCIB is a strategic move aimed at potentially increasing shareholder value and reflecting management's confidence in the company.
  6. The Toronto Stock Exchange has granted final acceptance for the NCIB.

Frequently Asked Questions

  1. What is a Normal Course Issuer Bid (NCIB)?

    A Normal Course Issuer Bid (NCIB) is a program where a public company repurchases its own outstanding shares from the open market. This is typically done through a stock exchange and is subject to regulatory approval, such as the acceptance by the Toronto Stock Exchange in this case. Companies undertake NCIBs to return capital to shareholders, reduce the number of outstanding shares (potentially increasing earnings per share), and signal confidence in the company's valuation.

  2. Why is Celestica Inc. repurchasing its shares?

    Celestica Inc. is repurchasing its shares through an NCIB as a way to return capital to its shareholders. This action can also help to enhance shareholder value by reducing the number of outstanding shares, which may lead to higher earnings per share. Management may also believe that the company's stock is currently undervalued in the market.

  3. How many shares will Celestica repurchase and over what period?

    Celestica plans to repurchase up to 5,722,527 of its common shares. This amount represents approximately 5% of the company's outstanding public float as of October 20, 2025. The repurchase program will commence on November 3, 2025, and is scheduled to conclude on November 2, 2026, meaning it will run for a full 12-month period.

  4. Does this NCIB mean Celestica is in financial trouble?

    No, quite the opposite. An NCIB is generally viewed as a positive sign. It indicates that the company has sufficient financial resources to repurchase its shares and that management believes the company's stock is trading at an attractive valuation. It's a strategy to enhance shareholder returns and manage the capital structure.